SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about analyst meet

19 Jun 2025 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the Listing Regulations, Lupin has informed that the Company will be participating in Nuvama - Specialty Chemicals and Healthcare Investor Conference on June 25, 2025 (In person).

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2364.10 12.20 (0.52%)
22-Jun-2026 09:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1840.00
Dr. Reddys Lab 1278.35
Cipla 1384.00
Zydus Lifesciences 1072.05
Lupin 2364.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: